1. Home
  2. ONTO vs PODD Comparison

ONTO vs PODD Comparison

Compare ONTO & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Onto Innovation Inc.

ONTO

Onto Innovation Inc.

HOLD

Current Price

$274.80

Market Cap

9.4B

Sector

Industrials

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$146.37

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONTO
PODD
Founded
1940
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4B
10.3B
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
ONTO
PODD
Price
$274.80
$146.37
Analyst Decision
Strong Buy
Buy
Analyst Count
8
21
Target Price
$290.63
$341.48
AVG Volume (30 Days)
1.1M
1.6M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.67
1.30
Revenue
N/A
$2,708,100,000.00
Revenue This Year
$26.63
$24.55
Revenue Next Year
$16.26
$19.18
P/E Ratio
$417.88
$110.23
Revenue Growth
N/A
30.73
52 Week Low
$89.40
$140.63
52 Week High
$316.00
$354.88

Technical Indicators

Market Signals
Indicator
ONTO
PODD
Relative Strength Index (RSI) 55.11 38.39
Support Level $274.97 $143.11
Resistance Level $312.85 $205.95
Average True Range (ATR) 13.51 5.77
MACD 0.49 1.23
Stochastic Oscillator 87.28 36.83

Price Performance

Historical Comparison
ONTO
PODD

About ONTO Onto Innovation Inc.

Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: